Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. KVK Tech, Inc.
WARNING LETTER
•KVK Tech, Inc.•April 16, 2019

KVK Tech, Inc. – FDA Warning Letter, Apr 16, 2019

Record Details

The FDA issued a Warning Letter to KVK-Tech, Inc. following an inspection from April 9-16, 2019, identifying significant CGMP violations, rendering their drug products adulterated.

Key violations include: 1. **Failure to establish and document test method accuracy (21 CFR 211.165(e))**: The firm improperly integrated co-eluting peaks during impurity testing of phentermine HCL capsules, leading to missed OOS results. A lot remained on the market until it failed stability testing in June 2017, despite self-identifying the issue in 2016 and conducting training. An SOP cleared by their quality unit contained inadequate integration examples. 2. **Failure to thoroughly investigate discrepancies (21 CFR 211.192)**: Foreign particles found in methylphenidate oral solution Lot #15315A were not adequately investigated for origin or effect on quality before release. This lot was later recalled. 3. **Inadequate computer system controls (21 CFR 211.68(b))**: Laboratory data was not adequately protected from deletion or alteration. Quality assurance employees had administrator access to chromatographic software, and data files on stand-alone equipment could be modified without audit trails. Previous corrective actions for data integrity were not fully implemented.

The FDA expressed concern about the firm's data integrity and recommended retaining

Company
KVK Tech, Inc.
Inspection date
April 16, 2019
Product type
Drugs
Office
Division of Pharmaceutical Quality Operations I
People
  • Diana Amador-Toro (District Director)
  • Lisa Orr (Market Manager)
View Company Profile

ID · e52dd09d-9479-459b-9c2a-bdacc44782a5

Violation Codes8
21 CFR 21021 CFR 21121 CFR 211.165(e)21 CFR 211.19221 CFR 211.68(b)FD&C Act 501(a)(2)(B)21 U.S.C. 356C(b)21 U.S.C. 351(a)(2)(B)

Full citation text and observation details available on the Dashboard.

Other documents for KVK Tech, Inc.
  • 483 - 2025-03-14March 14, 2025
  • 483 - 2022-07-08July 8, 2022
  • 483 - 2021-06-11June 11, 2021
  • WARNING_LETTER - 2020-03-13March 13, 2020
  • 483 - 2019-04-16April 16, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore KVK Tech, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.